Tags

Type your tag names separated by a space and hit enter

Guidelines for the management of tinea capitis in children.
Pediatr Dermatol. 2010 May-Jun; 27(3):226-8.PD

Abstract

Practice guidelines for the treatment of tinea capitis (TC) from the European Society for Pediatric Dermatology are presented. Tinea capitis always requires systemic treatment because topical antifungal agents do not penetrate the hair follicle. Topical treatment is only used as adjuvant therapy to systemic antifungals. The newer oral antifungal agents including terbinafine, itraconazole, and fluconazole appear to have efficacy rates and potential adverse effects similar to those of griseofulvin in children with TC caused by Trichophyton species, while requiring a much shorter duration of treatment. They may be, however, more expensive (Grading of recommendation A; strength of evidence 1a). Griseofulvin is still the treatment of choice for cases caused by Microsporum species. Its efficacy is superior to that of terbinafine (Grading of recommendation A; strength of evidence 1b), and although its efficacy and treatment duration is matched by fluconazole (Grading of recommendation A; strength of evidence 1b) and itraconazole (Grading of recommendation A; strength of evidence 1b), griseofulvin is cheaper. It must be noted, however, that griseofulvin is nowadays not available in certain European countries (e.g., Belgium, Greece, Portugal, and Turkey).

Authors+Show Affiliations

First Pediatric Department, Athens University, Aghia Sophia Children's Hospital, Athens, Greece.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

20609140

Citation

Kakourou, Talia, et al. "Guidelines for the Management of Tinea Capitis in Children." Pediatric Dermatology, vol. 27, no. 3, 2010, pp. 226-8.
Kakourou T, Uksal U, European Society for Pediatric Dermatology. Guidelines for the management of tinea capitis in children. Pediatr Dermatol. 2010;27(3):226-8.
Kakourou, T., & Uksal, U. (2010). Guidelines for the management of tinea capitis in children. Pediatric Dermatology, 27(3), 226-8. https://doi.org/10.1111/j.1525-1470.2010.01137.x
Kakourou T, Uksal U, European Society for Pediatric Dermatology. Guidelines for the Management of Tinea Capitis in Children. Pediatr Dermatol. 2010 May-Jun;27(3):226-8. PubMed PMID: 20609140.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Guidelines for the management of tinea capitis in children. AU - Kakourou,Talia, AU - Uksal,Umit, AU - ,, PY - 2010/7/9/entrez PY - 2010/7/9/pubmed PY - 2010/10/26/medline SP - 226 EP - 8 JF - Pediatric dermatology JO - Pediatr Dermatol VL - 27 IS - 3 N2 - Practice guidelines for the treatment of tinea capitis (TC) from the European Society for Pediatric Dermatology are presented. Tinea capitis always requires systemic treatment because topical antifungal agents do not penetrate the hair follicle. Topical treatment is only used as adjuvant therapy to systemic antifungals. The newer oral antifungal agents including terbinafine, itraconazole, and fluconazole appear to have efficacy rates and potential adverse effects similar to those of griseofulvin in children with TC caused by Trichophyton species, while requiring a much shorter duration of treatment. They may be, however, more expensive (Grading of recommendation A; strength of evidence 1a). Griseofulvin is still the treatment of choice for cases caused by Microsporum species. Its efficacy is superior to that of terbinafine (Grading of recommendation A; strength of evidence 1b), and although its efficacy and treatment duration is matched by fluconazole (Grading of recommendation A; strength of evidence 1b) and itraconazole (Grading of recommendation A; strength of evidence 1b), griseofulvin is cheaper. It must be noted, however, that griseofulvin is nowadays not available in certain European countries (e.g., Belgium, Greece, Portugal, and Turkey). SN - 1525-1470 UR - https://www.unboundmedicine.com/medline/citation/20609140/Guidelines_for_the_management_of_tinea_capitis_in_children_ L2 - https://doi.org/10.1111/j.1525-1470.2010.01137.x DB - PRIME DP - Unbound Medicine ER -